Hantz Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Hantz Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	10	–	–	﹤0.01%	2321
2026 Q1	$2K	Sell	10 -71	-88%	-$12.1K	﹤0.01%	2289
2025 Q4	$14K	Buy	81 +31	+62%	+$5.04K	﹤0.01%	1904
2025 Q3	$7K	Buy	+50	New	+$6.83K	﹤0.01%	1933
2025 Q1	–	Sell	-30	Closed	-$4K	–	1826
2024 Q4	$4K	Hold	30	–	–	﹤0.01%	920
2024 Q3	$4K	Hold	30	–	–	﹤0.01%	897
2024 Q2	$4K	Hold	30	–	–	﹤0.01%	883
2024 Q1	$4K	Hold	30	–	–	﹤0.01%	970
2023 Q4	$4K	Hold	30	–	–	﹤0.01%	944
2023 Q3	$4K	Hold	30	–	–	﹤0.01%	940
2023 Q2	$4K	Hold	30	–	–	﹤0.01%	919
2023 Q1	$4K	Hold	30	–	–	﹤0.01%	925
2022 Q4	$4K	Hold	30	–	–	﹤0.01%	894
2022 Q3	$4K	Hold	30	–	–	﹤0.01%	878
2022 Q2	$4K	Buy	+30	New	+$3.56K	﹤0.01%	879

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Hantz Financial Services's IBB Position: Q2 2026 in Review

Hantz Financial Services held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

Hantz Financial Services first reported a position in IBB in Q2 2022 and has held it in 15 quarters since. The position peaked at $14K in Q4 2025. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Hantz Financial Services held 10 shares of iShares Biotechnology ETF worth $2K as of Q2 2026.
Hantz Financial Services left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2321 holding.
Hantz Financial Services first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 15 quarters since.
Hantz Financial Services's iShares Biotechnology ETF position peaked at $14K in Q4 2025.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.